What question did this study set out to answer?

The aim was to evaluate survival and treatment disparities in elderly patients with mycosis fungoides and Sézary syndrome based on facility type.

Survival and socioeconomic disparities in the elderly population with mycosis fungoides and Sézary syndrome: A comparative analysis of 2,690 patients by facility type.

View Full Paper

Ask AI

Bookmark

The aim was to evaluate survival and treatment disparities in elderly patients with mycosis fungoides and Sézary syndrome based on facility type.
Conducted a retrospective cohort analysis using the National Cancer Database from 2000 to 2020.
Identified 2690 patients aged ≥75 with mycosis fungoides or Sézary syndrome, comparing treatment and outcomes between Academic and Community Cancer Programs.
Survival analysis utilized Kaplan-Meier and Cox proportional hazards models.
Patients at Academic Cancer Programs had a statistically significant longer median overall survival (4.9 vs 3.0 years, log-rank p=0.001).
Higher 2-, 5-, and 10-year survival rates were noted for ACP patients compared to CCP patients.
Systemic treatment was more frequent in ACPs (71% vs 65%, p<0.05), along with shorter median treatment initiation times (37 vs 48 days, p<0.05).

No takes yet. Share an insight, caveat, or question.

Comparative analysis demonstrates survival advantage in elderly patients treated at Academic Cancer Programs versus Community settings.

Hinojosa et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark